Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Temenos (TEMN.S)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (CHF) Price Target (CHF) Rating
2022-03-3095.0893.00Sell
2022-04-1286.9084.50Sell
2022-08-0377.2866.30Sell
2022-10-2858.9055.70Sell
2023-02-2068.1458.70Sell
2023-04-2563.1459.00Sell
2023-11-1066.8463.50Sell
2024-01-2386.3269.50Sell
2024-02-2062.2456.00Sell
2024-04-2458.9053.00Sell
2024-07-2560.9551.00Sell
2024-10-2463.7549.50Sell
2025-02-1976.2054.00Sell
2025-04-2357.5546.00Sell

Disclosures

  • UBS has acted as manager/co-manager in the underwriting or placement of securities of this company/entity or one of its affiliates within the past 12 months.
  • Within the past 12 months, UBS has received compensation for investment banking services from this company/entity or one of its affiliates.
  • UBS expects to receive or intend to seek compensation for investment banking services from this company/entity within the next three months.
  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
  • UBS Fund Management (Switzerland) AG beneficially owns more than 5% of the total issued share capital of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.